Effect of a Histone Deacetylase Inhibitor on Human Cardiac Mass

Author： Shizukuda Yukitaka Piekarz Richard Bates Susan Sachdev Vandana Finkel Toren Rosing Douglas

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.19, Iss.1, 2005-01, pp. : 89-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Romidepsin: a novel histone deacetylase inhibitor for cancer

By Bertino Erin M Otterson Gregory A

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1151-1158

Informa Healthcare

Access to resources Recommend Favorite

In Vitro Investigation of the Hepatic Intrinsic Clearance of Apicidin, a Histone Deacetylase Inhibitor, in Mouse, Rat, and Human, with Correction by Nonspecific Protein Binding

By Soo Shin Beom Hye Park Eun Ho Yoon Chi Kim John Zee Okpyo Dong Yoo Sun

Journal of Toxicology and Environmental Health, Vol. 68, Iss. 23-24, 2005-12 ,pp. : 2207-2218

Taylor & Francis Ltd

Access to resources Recommend Favorite

A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl- XL

By Hwang Jung

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1434-1442

Springer Publishing Company

Access to resources Recommend Favorite

Emerging role of the histone deacetylase inhibitor romidepsin in hematologic malignancies

By Jain Nitin Odenike Olatoyosi

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 18, 2010-12 ,pp. : 3073-3084

Informa Healthcare

Access to resources Recommend Favorite

Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitor

By Boumber Yanis Younes Anas Garcia-Manero Guillermo

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 6, 2011-06 ,pp. : 823-829

Informa Healthcare

Access to resources Recommend Favorite